EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 107 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,902,255 | -6.3% | 3,492,147 | +2.0% | 1.51% | -5.3% |
Q2 2023 | $29,787,904 | +198.4% | 3,423,897 | +0.9% | 1.59% | +277.5% |
Q1 2023 | $9,980,997 | -14.8% | 3,394,897 | +1.4% | 0.42% | -14.2% |
Q4 2022 | $11,717,640 | -54.2% | 3,347,897 | +3.5% | 0.49% | -53.7% |
Q3 2022 | $25,578,000 | +9.5% | 3,233,597 | +8.9% | 1.06% | +19.6% |
Q2 2022 | $23,360,000 | -33.9% | 2,968,207 | +2.0% | 0.89% | -17.8% |
Q1 2022 | $35,349,000 | +14.6% | 2,909,407 | +15.5% | 1.08% | +80.9% |
Q4 2021 | $30,841,000 | +73.6% | 2,519,700 | +47.8% | 0.60% | +99.7% |
Q3 2021 | $17,762,000 | +43.3% | 1,704,589 | +23.7% | 0.30% | +61.6% |
Q2 2021 | $12,391,000 | +3.2% | 1,378,332 | +16.7% | 0.18% | +4.5% |
Q1 2021 | $12,001,000 | – | 1,181,200 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 4,190,921 | $36,461,013 | 27.59% |
ACUTA CAPITAL PARTNERS, LLC | 382,000 | $3,323,400 | 2.25% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,423,897 | $29,787,904 | 1.59% |
Cormorant Asset Management, LP | 3,200,000 | $27,840,000 | 1.56% |
Caligan Partners LP | 310,298 | $2,699,593 | 1.52% |
Samsara BioCapital, LLC | 432,000 | $3,758,400 | 0.66% |
RA Capital Management | 3,370,506 | $29,323,402 | 0.55% |
SECTORAL ASSET MANAGEMENT INC | 311,277 | $2,708,110 | 0.45% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 209,949 | $1,826,556 | 0.26% |
BARD ASSOCIATES INC | 30,674 | $266,864 | 0.10% |